RYKAX | VFAIX | RYKAX / VFAIX | |
Total Expense Ratio | 1.65 | 0.09 | 1,833% |
Annual Report Gross Expense Ratio | 1.69 | 0.09 | 1,878% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | 0.023 | 2.553 | 1% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.5M | 13B | 0% |
Annual Yield % from dividends | 3.83 | 1.77 | 216% |
Returns for 1 year | 25.20 | 22.59 | 112% |
Returns for 3 years | 30.62 | 58.01 | 53% |
Returns for 5 years | 82.01 | 106.89 | 77% |
Returns for 10 years | 66.73 | 141.11 | 47% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QBER | 24.70 | 0.04 | +0.16% |
TrueShares Quarterly Bear Hedge ETF | |||
LVHD | 39.71 | -0.36 | -0.90% |
Franklin U.S. Low Volatility Hi Div ETF | |||
PBE | 63.94 | -0.80 | -1.24% |
Invesco Biotechnology & Genome ETF | |||
EUDG | 35.04 | -0.53 | -1.50% |
WisdomTree Europe Quality Div Gr ETF | |||
MDYG | 83.95 | -1.44 | -1.69% |
SPDR® S&P 400 Mid Cap Growth ETF |